Alexandre Avraméas

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease

Ulf Neumann, Mike Ufer, Laura H. Jacobson et al. · EMBO Molecular Medicine · 2018 · 172 citations · Full text

Medicine, Neuroscience, Pharmacology +12

Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies

Marie‐Anne Valentin, Shenglin Ma, An Sha Zhao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2011 · 145 citations

Pharmacy, Clinical Sciences, Proteomics +13

Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study

Benjamin A. Fisher, Antónia Szántó, Wan‐Fai Ng et al. · The Lancet Rheumatology · 2020 · 126 citations

Life Sciences, Clinical Sciences, Immunology +14

Expression of a mannose/fucose membrane lectin on human dendritic cells

Alexandre Avraméas, Dorian McIlroy, Anne Hosmalin et al. · European Journal of Immunology · 1996 · 118 citations

Life Sciences, Cell Biology, Immunology +17

First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody

Pascal Espié, Yanling He, Phillip J. Koo et al. · American Journal of Transplantation · 2019 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +17